What is Repaglinide 1 mg?
Repaglinide 1 mg is an oral medication prescribed primarily for managing type 2 diabetes mellitus. It belongs to the meglitinide class of drugs and contains the active ingredient Repaglinide. This medication works by stimulating your pancreas to release insulin, helping to regulate blood sugar levels effectively. Manufactured by Novo Nordisk India, Repaglinide is trusted worldwide for its efficacy and safety profile.
In Canada and other countries, Repaglinide 1 mg is a valuable option for patients struggling to achieve optimal glycemic control with diet and exercise alone. It is often used as part of a comprehensive diabetes management plan, which may include lifestyle changes and other medications. This medicine is especially suitable for people who experience fluctuating blood glucose levels after meals, as it helps to control postprandial glucose spikes.
Uses of Repaglinide 1 mg
- Management of type 2 diabetes mellitus
- Control of postprandial blood glucose levels
- Used alongside diet and exercise to improve glycemic control
- Alternative for patients intolerant to other oral antidiabetic agents
How Repaglinide 1 mg Works
Repaglinide 1 mg functions by stimulating pancreatic beta cells to secrete insulin. It acts quickly after ingestion, targeting the rapid rise in blood sugar that occurs following meals. By enhancing insulin release, Repaglinide helps cells utilize glucose more effectively, reducing blood sugar levels and preventing hyperglycemia. Unlike some other diabetes medicines, it has a rapid onset and short duration of action, allowing flexible dosing with meals. This mechanism helps minimize the risk of hypoglycemia when taken correctly.
Benefits of Repaglinide 1 mg
- Effective control of blood glucose levels
- Rapid action tailored to meal times
- Improves insulin secretion naturally
- Flexible dosing schedule
- Minimal long-term accumulation in the body
- May be combined safely with other antidiabetic medications
Dosage and Administration
Repaglinide 1 mg is typically taken orally before meals. The exact dose depends on individual blood glucose response and medical consultation. Usually, the medication is administered 15 to 30 minutes prior to eating to optimize blood sugar control. Patients are advised not to skip meals after taking Repaglinide to avoid low blood sugar episodes. Dosage adjustments may be necessary based on blood sugar monitoring and healthcare professional guidance, especially in patients with kidney or liver impairment.
Who Should Use Repaglinide 1 mg?
Repaglinide 1 mg is intended for adults diagnosed with type 2 diabetes who require improved glycemic control. It is appropriate for patients who do not respond adequately to diet and exercise alone. Those experiencing elevated postprandial blood glucose levels may benefit from this treatment as it targets meal-related glucose spikes effectively. It can also be considered for patients who have intolerance or contraindications to other oral antidiabetic drugs but need insulin stimulation.
Who Should Avoid Repaglinide 1 mg?
Repaglinide 1 mg is not recommended for individuals with type 1 diabetes mellitus or diabetic ketoacidosis. Patients with known hypersensitivity to Repaglinide or any ingredients in the formulation should avoid this medicine. Caution is advised in people with severe liver or kidney impairment, and dosage adjustments may be required. Pregnant and breastfeeding women should seek medical advice before use. Individuals prone to frequent hypoglycemia or with irregular meal patterns should also use this medication carefully under supervision.
Side Effects
- Low blood sugar (hypoglycemia)
- Headache
- Dizziness
- Nausea
- Diarrhea
- Allergic skin reactions
- Weight gain
- Joint pain
- Fatigue
Safety Advice
- Take Repaglinide 1 mg strictly as prescribed
- Do not skip meals after taking medication
- Monitor blood glucose regularly to detect hypoglycemia
- Inform your doctor about all medications and supplements being used
- Avoid alcohol while using Repaglinide
- Carry sugary snacks to treat sudden low blood sugar episodes
- Consult your healthcare provider before any dose changes
Drug Interactions
- Other antidiabetic drugs may increase hypoglycemia risk
- Certain antibiotics like clarithromycin may affect blood sugar control
- Drugs such as gemfibrozil may increase Repaglinide levels
- Rifampin can reduce Repaglinide effectiveness
- Non-steroidal anti-inflammatory drugs (NSAIDs) may alter blood glucose
- Beta-blockers can mask hypoglycemia symptoms
Storage Instructions
Store Repaglinide 1 mg tablets at room temperature, between 15°C and 30°C. Keep the medication away from moisture, heat, and direct sunlight. Ensure the bottle or packaging is tightly closed when not in use. Keep out of reach of children and pets. Do not use the medicine beyond the expiry date printed on the label.
Where to buy Repaglinide 1 mg in Canada?
Repaglinide 1 mg is available at licensed pharmacies across Canada. You can buy this medicine with a prescription from a healthcare provider. It is also accessible through reputable online Canadian pharmacies offering safe and genuine products. Prioritize purchasing from trusted sources to ensure medication quality and adherence to Canadian healthcare regulations.
Frequently Asked Questions (FAQ)
Is Repaglinide 1 mg available in Canada?
Yes, Repaglinide 1 mg is available in Canada by prescription and can be obtained from licensed pharmacies.
What is the price of Repaglinide 1 mg in Canada?
Prices vary depending on the pharmacy and insurance coverage, but Repaglinide 1 mg is generally affordable. It is best to check with local pharmacies for specific pricing.
What happens if I miss a dose?
If you miss a dose, take it as soon as you remember, but only if it is shortly before a meal. If it is near the time of your next meal, skip the missed dose. Do not double the dose to catch up.
Where can I find Repaglinide 1 mg for sale?
You can find Repaglinide 1 mg at community pharmacies and certified online pharmacies in Canada. Always ensure the supplier is legitimate to guarantee medication safety.
Can Repaglinide 1 mg cause low blood sugar?
Yes, hypoglycemia is a possible side effect, especially if meals are skipped or combined with other antidiabetics. Monitoring and adherence to dosing instructions reduce this risk.
Can I take Repaglinide 1 mg with other diabetes medications?
Yes, but only under medical supervision, as combining therapies may increase hypoglycemia risk and require dose adjustments.
Is it safe to use Repaglinide 1 mg if I have kidney problems?
Caution is advised for patients with kidney impairment. Consult your doctor, who may adjust your dose or suggest alternatives.
Conclusion
Repaglinide 1 mg is a reliable and effective treatment option for adults managing type 2 diabetes, especially for controlling post-meal blood sugar spikes. Manufactured by Novo Nordisk India, it offers the benefit of rapid insulin release with flexible dosing. When used responsibly and according to medical advice, Repaglinide supports improved glycemic control and enhances overall diabetes management. Patients in Canada seeking an accessible and professional medication can confidently consider Repaglinide 1 mg as part of their treatment plan.
Leave A Review